Madden Securities’s Definium Therapeutics DFTX Stock Holding History

Madden Securities’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.09K	Buy	+160	New	+$6.74K	﹤0.01%	303

Other funds holding DFTX

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Peak Financial Advisors Denver, Colorado $232M AUM 12.16% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Madden Securities's DFTX Position: Q3 2026 in Review

Madden Securities opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 160 shares worth $6.09K. The stake represents ﹤0.01% of the portfolio and ranks #303 among its holdings.

74 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

Madden Securities held 160 shares of Definium Therapeutics worth $6.09K as of Q3 2026.
Definium Therapeutics was a new Madden Securities position in Q3 2026.
Definium Therapeutics made up ﹤0.01% of Madden Securities's portfolio in Q3 2026, its #303 holding.
74 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Madden Securities's 13F filing for Q3 2026, filed 27 Oct 2026.